Subject(s)
Humans , Staphylococcal Infections/drug therapy , Methicillin Resistance , Staphylococcus aureus/drug effects , Cross Infection/microbiology , Cross Infection/prevention & control , Community-Acquired Infections/microbiology , Community-Acquired Infections/prevention & control , Staphylococcal Infections/microbiologyABSTRACT
Enterococcus faecalis isolates were examined by an automated identification and susceptibility system. Almost all of the 97 isolates were ampicillin susceptible (n = 86) and tetracycline resistant (n = 89). All were nitrofurantoin susceptible. About a third of isolates showed high level resistance to the aminoglycosides streptomicin and gentamicin and this was usually associated with ciprofloxacin resistance (n = 34). Seven isolates were vancomycin resistant, including one that was ampicillin resistant. Most forms of resistance described elsewhere were found.
Aislados de enterococcus faecalis fueron examinados mediante un sistema automatizado de identificación y susceptibilidad. Casi todos los 97 aislados examinados fueron susceptibles a la ampi-cilina (n = 86) y resistentes a la tetraciclina (n = 89). Todos fueron susceptibles a la nitrofurantoína. Alrededor de una tercera parte de los aislados mostró un alto nivel de resistencia a los aminoglicósidos, por regla general asociada con la resistencia a la ciprofloxacina (n=34). Siete aislados resultaron resistentes a la vancomicina, incluyendo uno que fue resistente a la ampicilina. Se encontraron la mayoría de las formas de resistencia descritas en otras partes.
Subject(s)
Humans , Anti-Bacterial Agents/pharmacology , Enterococcus faecalis/drug effects , Hospitals, University/statistics & numerical data , Cross Infection/microbiology , Gram-Positive Bacterial Infections/microbiology , Nitrofurantoin/pharmacology , Drug Resistance, Bacterial , Ampicillin/pharmacology , Cross Infection/epidemiology , Cross Infection/prevention & control , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/prevention & control , Jamaica , Microbial Sensitivity Tests , Tetracycline/pharmacologyABSTRACT
This paper describes the devastating outcome of a neonate who presented with severe late onset group B beta-haemolytic streptococcal (GBS) disease. There were extensive infarcts of the brain and gangrene of the toes. The purpose of this report is to alert healthcare workers of the unusual presentation and that fatal late onset group B beta-haemolytic streptococcal disease may occur despite early and effective management